XML 24 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity - USD ($)
$ in Thousands
Total
Series G redeemable convertible preferred stock
Series H redeemable convertible preferred stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2018 532,606,084          
Beginning balance at Dec. 31, 2018 $ 105,232          
Increase (Decrease) in Temporary Equity [Roll Forward]            
Accretion of redeemable convertible preferred stock 4,640          
Issuance of Series redeemable convertible preferred stock for aggregate proceeds, net of issuance costs (in shares)   148,928,337 233,446,519      
Issuance of Series redeemable convertible preferred stock for aggregate proceeds, net of issuance costs   $ 11,492 $ 3,941      
Deemed dividend recognized on beneficial conversion features of Series H redeemable convertible preferred stock (Note 7) $ 6,741   6,741      
Deemed dividend from conversion of Series G to Series H redeemable convertible preferred stock (Note 7) (in shares) 97,592,739          
Deemed dividend from conversion of Series G to Series H redeemable convertible preferred stock (Note 7) $ 6,860          
Conversion of preferred stock to common stock in connection with initial public offering (in shares) (1,012,573,679)          
Conversion of preferred stock to common stock in connection with initial public offering (Note 7) $ (138,906)          
Ending balance (in shares) at Dec. 31, 2019 0          
Ending balance at Dec. 31, 2019 $ 0          
Beginning balance (in shares) at Dec. 31, 2018       63,005    
Beginning balance at Dec. 31, 2018 (111,966)     $ 0 $ 40,598 $ (152,564)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Accretion of redeemable convertible preferred stock (4,640)       (4,640)  
Exercise of stock options (in shares)       1,548    
Exercise of stock options 4       4  
Stock-based compensation 572       572  
Issuance of Series H redeemable convertible preferred stock for aggregate proceeds of $0.047 per share, net of issuance costs of $318 (Note 7) 6,741       6,741  
Deemed dividend recognized on beneficial conversion features of Series H redeemable convertible preferred stock (Note 7) (6,741)       (6,741)  
Deemed dividend from conversion of Series G to Series H redeemable convertible preferred stock (Note 7) (6,860)       (6,860)  
Conversion of preferred stock to common stock in connection with initial public offering (Noted 7) (in shares)       7,816,643    
Conversion of preferred stock to common stock in connection with initial public offering (Note 7) 138,906     $ 8 138,898  
Issuance of common stock in initial public offering, net of underwriting discount, commissions and issuance costs (Note 8) (in shares)       4,140,000    
Issuance of common stock in initial public offering, net of underwriting discount, commissions and issuance costs (Note 8) 50,444     $ 4 50,440  
Net exercise of common and preferred stock warrants (in shares)       539,794    
Net exercise of common and preferred stock warrants 511     $ 1 510  
Reclassification of redeemable convertible preferred stock warrant liabilities as equity 726       726  
Net loss $ (12,038)         (12,038)
Ending balance (in shares) at Dec. 31, 2019 12,560,990     12,560,990    
Ending balance at Dec. 31, 2019 $ 55,659     $ 13 220,248 (164,602)
Increase (Decrease) in Temporary Equity [Roll Forward]            
Accretion of redeemable convertible preferred stock $ 0          
Deemed dividend recognized on beneficial conversion features of Series H redeemable convertible preferred stock (Note 7)     $ 0      
Ending balance (in shares) at Dec. 31, 2020 0          
Ending balance at Dec. 31, 2020 $ 0          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares) 47,549     47,549    
Exercise of stock options $ 13       13  
Stock-based compensation 2,694       2,694  
Net exercise of common and preferred stock warrants (in shares)       32,120    
Net exercise of common and preferred stock warrants 18       18  
Issuance of stock under Employee Stock Purchase Plan (in shares)       11,649    
Issuance of stock under Employee Stock Purchase Plan 142       142  
Net loss $ (16,687)         (16,687)
Ending balance (in shares) at Dec. 31, 2020 12,652,308     12,652,308    
Ending balance at Dec. 31, 2020 $ 41,839     $ 13 $ 223,115 $ (181,289)